Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
lamotrigin ratiopharm dreifitafla 100 mg
ratiopharm gmbh* - lamotriginum inn - dreifitafla - 100 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
lamotrigin ratiopharm dreifitafla 200 mg
ratiopharm gmbh* - lamotriginum inn - dreifitafla - 200 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
lamotrigin ratiopharm dreifitafla 25 mg
ratiopharm gmbh* - lamotriginum inn - dreifitafla - 25 mg
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
briviact (in italy: nubriveo)
ucb pharma sa - brivaracetam - flogaveiki - antiepileptics, - briviact er ætlað sem viðbótarmeðferð við meðhöndlun á flogaveiki með eða án aukakvilla hjá fullorðnum og unglingum frá 16 ára aldri með flogaveiki.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
lamictal tuggu-/dreifitafla 50 mg
glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 50 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
lamictal tuggu-/dreifitafla 5 mg
glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
lamictal tuggu-/dreifitafla 25 mg
glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 25 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
lamictal tuggu-/dreifitafla 200 mg
glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 200 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
lamictal tuggu-/dreifitafla 2 mg
glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 2 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
lamictal tuggu-/dreifitafla 100 mg
glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 100 mg